Complexity of continuous glucose monitoring data in critically ill patients: Continuous glucose monitoring devices, sensor locations, and detrended fluctuation analysis methods

Journal of Diabetes Science and Technology

Volumn 7, Issue 6, 2013, Pages 1492-1506

  Signal, Matthew ^a   Thomas, Felicity ^a   Shaw, Geoffrey M ^b   Chase, J Geoffrey ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Continuous glucose monitoring; Detrended fluctuation; Detrended fluctuation analysis; Fractal; Sensor

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CALIBRATION; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING DEVICE; CRITICALLY ILL PATIENT; FEMALE; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE;

ABDOMEN; ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; CRITICAL ILLNESS; FEMALE; FRACTALS; HUMANS; HYPERGLYCEMIA; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; THIGH;

EID: 84900527377     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700609     Document Type: Article

References (35)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355(9206):773-8.
2. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003;290(15):2041-7.
3. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471-8.
4. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17(1):107-24.
5. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15(4):533-51.
6. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-82.
7. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359-66.
8. Bistrian BR. Hyperglycemia and infection: which is the chicken and which is the egg? JPEN J Parenter Enteral Nutr. 2001;25(4):180-1.
9. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
10. Chase JG, Shaw G, Le Compte A, Lonergan T, Willacy M, Wong XW, Lin J, Lotz T, Lee D, Hann C. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12(2):R49.
11. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79(8):992-1000.
12. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthof D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loefler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
13. Finfer S, Delaney A. Tight glycemic control in critically ill adults. JAMA. 2008;300(8):963-5.
14. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738-48.
15. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-7.
16. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244-52.
17. Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36(11):3008-13.
18. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-42.
19. Pidcoke HF, Wanek SM, Rohleder LS, Holcomb JB, Wolf SE, Wade CE. Glucose variability is associated with high mortality after severe burn. J Trauma. 2009;67(5):990-5.
20. Kaneki M, Sakai M, Shimizu N, Chang K. Is normalized mean blood glucose level good enough for the intensive care unit? - glycemic variability as a new independent predictor of mortality. Crit Care Med. 2008;36(11):3104-6.
21. Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF Jr, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316-21.
22. Lundelin K, Vigil L, Bua S, Gomez-Mestre I, Honrubia T, Varela M. Diferences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study. Crit Care Med. 2010;38(3):849-54.
23. Brunner R, Adelsmayr G, Herkner H, Madl C, Holzinger U. Glycemic variability and glucose complexity in critically ill patients: a retrospective analysis of continuous glucose monitoring data. Crit Care. 2012;16(5):R175.
24. Lee JM, Kim DJ, Kim IY, Suk Park K, Kim SI. Nonlinear-analysis of human sleep EEG using detrended fluctuation analysis. Med Eng Phys. 2004;26(9):773-6.
25. Penzel T, Kantelhardt JW, Grote L, Peter JH, Bunde A. Comparison of detrended fluctuation analysis and spectral analysis for heart rate variability in sleep and sleep apnea. IEEE Trans Biomed Eng. 2003;50(10):1143-51.
26. Peng CK, Mietus JE, Liu Y, Lee C, Hausdorf JM, Stanley HE, Goldberger AL, Lipsitz LA. Quantifying fractal dynamics of human respiration: age and gender efects. Ann Biomed Eng. 2002;30(5):683-92.
27. Eke A, Herman P, Kocsis L, Kozak LR. Fractal characterization of complexity in temporal physiological signals. Physiol Meas. 2002;23(1):R1-38.
28. Goldberger AL, Amaral LA, Hausdorf JM, Ivanov PCh, Peng CK, Stanley HE. Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A. 2002;99 Suppl 1:2466-72.
29. Hausdorf JM, Purdon PL, Peng CK, Ladin Z, Wei JY, Goldberger AL. Fractal dynamics of human gait: stability of long-range correlations in stride interval fluctuations. J Appl Physiol (1985). 1996;80(5):1448-57.
30. Peng CK, Havlin S, Hausdorff JM, Mietus JE, Stanley HE, Goldberger AL. Fractal mechanisms and heart rate dynamics. Long-range correlations and their breakdown with disease. J Electrocardiol. 1995;28 Suppl:59-65.
31. Evans A, Le Compte A, Tan CS, Ward L, Steel J, Pretty CG, Penning S, Suhaimi F, Shaw GM, Desaive T, Chase JG. Stochastic targeted (STAR) glycemic control: design, safety, and performance. J Diabetes Sci Technol. 2012;6(1):102-15.
32. Ihlen EA. Introduction to multifractal detrended fluctuation analysis in matlab. Front Physiol. 2012;3:141.
33. Kantelhardt JW, Zschiegner SA, Koscielny-Bunde E, Havlin S, Bunde A, Stanley HE. Multifractal detrended fluctuation analysis of nonstationary time series," Physica A. 2002;316:87-114.
34. Medtronic Minimed. iPro2 user guide. 2010.
35. Medtronic Minimed. Guardian REAL-Time continuous glucose monitoring system user guide. 2006.